Safe IMPORT Act of 2005

H.R. 2345 Counterfeit Drug Enforcement Act of 2005 H.R. 4829 Reducing Fruadulant and Imitation Drug Act of 2005: S. 2300 Lower PRICED Drug Act. Meetings with Members of Congress regarding generic biologics and Food and Drug Administration regulatory activity of interest to the Registrant. Various bills regarding the importation of prescription drugs including: H.R. 328, S. 109, H.R. 700, S. 334. H.R. 753, and S. 184. H.R. 5993, S. 3695: legislation to prohibit the marketing of authorized generic drugs.

Client expense: $440,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Pharmaceutical issues, SCR 18; Pharmaceutical market access, S. 109, H.R. 328; Pharmaceutical importation, S. 184.

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Pharmaceutical importation, S.184

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.109, Pharmaceutical Market Access Act of 2005, S.184, Safe IMPORT Act of 2005, Safe Importation of Medical Products and Other Rx Therapies Act of 2005, S.334, Pharmaceutical Market Access and Drug Safety Act of 2005, General discussion regarding drug reimportation, pharmaceutical distribution issues, recent issues with importation and adulterated drugs, ordering and dispensing technology related to hospital pharmacy and out-patient pharmacy activities, drug pricing, prescription drug discount cards, internet drug sales, S.1551, Protecting Free Trade in Pharmaceuticals Act of 2005, H.R.2345, Counterfeit Drug Enforcement Act of 2005, H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005, FY2005 Appropriations Act for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, S.2668, Reducing Fraudulent and Imitation Drugs Act of 2006, S.2582, Preserve Access to Affordable Generics Act, H.R.5156, Counterfeit Drug Prevention Act of 2006, S.2315, Methamphetamine Awareness and Prevention Act of 2006, H.R.4763, Methamphetamine Education Act, H.R.4829, Reducing Fraudulent and Imitation Drugs Act of 2006 H.R.314, Combat Meth Act of 2005, H.R.328, Pharmaceutical Market Access Act of 2005, S.103, Combat Meth Act of 2005,

Client expense: Not reported · Firm income: $40,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 4127, Data Accountabilty and Trust Act; H.R. 3997, Financial Data Protection Act; H.R. 3374, Consumer Notification and Financial Data Protection Act; H.R. 3375, Financial Data Security Act; S. 1408, Identity Theft Protection Act; S. 3568, the Data Security Act of 2006; H.R. 5318, the Cyber-Security Enhancement and Consumer Data Protection Act. Implementation of the FACT Act. Issues related to the use of payment cards in connection with purchase of prescription medications over the Internet including provisions in: S. 184, Safe IMPORT Act of 2005; and S. 334, Pharmaceutical Market Access and Drug Safety Act of 2005. General issues relating to interchange fees; general issues relating to credit card practices. H.R. 4411, the Unlawful Internet Gambling Enforcement Act and H.R. 4777; the Internet Gambling Prohibition Act, provisions relating to financial services. Issues related to use of payment cards in connection with purchase of illegal material over the Internet. Issues related to reliance on payment card providers in connection with taxpayer compliance with the Internal Revenue Code. All provisions pertaining to data security, customer notification of security breaches, and mitigation of harm resulting from security breaches in the following legislation: S. 1332, Personal Data Privacy and Security Act; S. 768, Comprehensive Identity Theft Prevention Act;

Client expense: Not reported · Firm income: $320,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S184 And HR753, Safe Import Act Of 2005, Provisions And Issues Related To The Safety Of Imported Pharmaceuticals From Other Countries; HCR Provisions Or Amendments Relating To Importation On Senate Budget Resolution S. Con Res 83; HR4157, Better Health Information System Act, Provisions And Issues Related To The Stark Anti-Kickback Restrictions And Coordination And Planning For Interoperability Of Health IT (Information Technology). HR4157 Better Health Information System Act, Provisions And Issues Related The Safe Harbor Protections And Healthcare Price Transparency; S1955, Health Insurance Marketplace Modernization And Affordability Act;

Client expense: $3,674,234 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 22 Postal Accountability and Enhancement Act HR 184 Controlled Substances Export Reform Act of 2005 HR 218 Health Care Tax Deduction Act of 2005 HR 328 Pharmaceutical Market Access Act of 2005 HR 700 Pharmaceutical Market Access and Drug Safety Act of 2005 HR 753 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 HR 747 National Health Information Incentive Act of 2005 HR 1132 National All Schedules Prescription Electronic Reporting Act of 2005 HR 1223 Information Technology for Health Care Quality Act HR 4832 Electronic Health Information Technology Act of 2006 HR 4157 Health Information Technology Promotion Act of 2005 HR 5166 Independent Pharmacy Protection Act of 2006 HR 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 HR 1626 Medicare Prescription Drug Improvement Act HR 1669 Pharmacy Benefit Manager Transparency Act of 2005 HR 1671 Community Pharmacy Fairness Act of 2005 HR 1710 Internet Police Protection Act of 2005' HR 1808 Safe Online Drug Act of 2005 HR 2234 21st Century Health Information Act of 2005 HR 2664 Biennial Budgeting and Appropriations Act of 2005 HR 2774 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2006 HR 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2007 S 4 Healthy America Act of 2005 S 16 Affordable Health Care Act S 109 Pharmaceutical Market Access Act of 2005 S 184 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 S 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S 518 National All Schedules Prescription Electronic Reporting Act of 2005 S 662 Postal Accountability and Enhancement Act S 975 Project BiosSheild II Act of 2005 S 1223 Information Technology for Health Care Quality Act S 1227 Health Information Technology Act of 2005 S 1262 Health Technology to Enhance Quality Act of 2005 S 1418 Wired for Health Care Quality Act S 2072 Medicare Early Access Act of 2005 S 2090 Food and Drug Administration Act of 2005 S 2551 Prompt Payment of Health Benefits Claims Act of 2006 S 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 S. 2665 Pharmacy Access Improvement (PhAIm) Act of 2006 See next page

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 22 Postal Accountability and Enhancement Act HR 184 Controlled Substances Export Reform Act of 2005 HR 218 Health Care Tax Deduction Act of 2005 HR 328 Pharmaceutical Market Access Act of 2005 HR 700 Pharmaceutical Market Access and Drug Safety Act of 2005 HR 753 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 HR 747 National Health Information Incentive Act of 2005 HR 1132 National All Schedules Prescription Electronic Reporting Act of 2005 HR 1223 Information Technology for Health Care Quality Act HR 4832 Electronic Health Information Technology Act of 2006 HR 4157 Health Information Technology Promotion Act of 2005 HR 5166 Independent Pharmacy Protection Act of 2006 HR 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 HR 1626 Medicare Prescription Drug Improvement Act HR 1669 Pharmacy Benefit Manager Transparency Act of 2005 HR 1671 Community Pharmacy Fairness Act of 2005 HR 1710 Internet Police Protection Act of 2005' HR 1808 Safe Online Drug Act of 2005 HR 2234 21st Century Health Information Act of 2005 HR 2664 Biennial Budgeting and Appropriations Act of 2005 HR 2774 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2006 HR 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2007 S 4 Healthy America Act of 2005 S 16 Affordable Health Care Act S 109 Pharmaceutical Market Access Act of 2005 S 184 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 S 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S 518 National All Schedules Prescription Electronic Reporting Act of 2005 S 662 Postal Accountability and Enhancement Act S 975 Project BiosSheild II Act of 2005 S 1223 Information Technology for Health Care Quality Act S 1227 Health Information Technology Act of 2005 S 1262 Health Technology to Enhance Quality Act of 2005 S 1418 Wired for Health Care Quality Act S 2072 Medicare Early Access Act of 2005 S 2090 Food and Drug Administration Act of 2005 S 2551 Prompt Payment of Health Benefits Claims Act of 2006 S 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 S. 2665 Pharmacy Access Improvement (PhAIm) Act of 2006 See next page

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 22 Postal Accountability and Enhancement Act HR 184 Controlled Substances Export Reform Act of 2005 HR 218 Health Care Tax Deduction Act of 2005 HR 328 Pharmaceutical Market Access Act of 2005 HR 700 Pharmaceutical Market Access and Drug Safety Act of 2005 HR 753 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 HR 747 National Health Information Incentive Act of 2005 HR 1132 National All Schedules Prescription Electronic Reporting Act of 2005 HR 1223 Information Technology for Health Care Quality Act HR 4832 Electronic Health Information Technology Act of 2006 HR 4157 Health Information Technology Promotion Act of 2005 HR 5166 Independent Pharmacy Protection Act of 2006 HR 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 HR 1626 Medicare Prescription Drug Improvement Act HR 1669 Pharmacy Benefit Manager Transparency Act of 2005 HR 1671 Community Pharmacy Fairness Act of 2005 HR 1710 Internet Police Protection Act of 2005' HR 1808 Safe Online Drug Act of 2005 HR 2234 21st Century Health Information Act of 2005 HR 2664 Biennial Budgeting and Appropriations Act of 2005 HR 2774 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2006 HR 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2007 S 4 Healthy America Act of 2005 S 16 Affordable Health Care Act S 109 Pharmaceutical Market Access Act of 2005 S 184 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 S 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S 518 National All Schedules Prescription Electronic Reporting Act of 2005 S 662 Postal Accountability and Enhancement Act S 975 Project BiosSheild II Act of 2005 S 1223 Information Technology for Health Care Quality Act S 1227 Health Information Technology Act of 2005 S 1262 Health Technology to Enhance Quality Act of 2005 S 1418 Wired for Health Care Quality Act S 2072 Medicare Early Access Act of 2005 S 2090 Food and Drug Administration Act of 2005 S 2551 Prompt Payment of Health Benefits Claims Act of 2006 S 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 S. 2665 Pharmacy Access Improvement (PhAIm) Act of 2006 See next page

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S 366 - 'Healthy Mothers & Healthy Babies Access to Care Act of 2005' All provisions pertaining to the bill. S 367 - 'Pregnancy & Trauma Care Access Protection Act of 2005' All provisions pertaining to the bill. S 406 - 'H.E.A.L.T.H. (Help Efficient, Accessible, Low-Cost, Timely Health Care) Act' All provisions pertaining to the bill. S544 - 'Patient Safety and Quality Improvement Act' All provisions pertaining to the bill. S 723 - 'SIMPLE Cafeteria Plan Act' All provisions pertaining to the bill. S 978 - 'Health Care Tax Relief for the Uninsured Act of 2005 ' All provisions pertaining to the bill. S 1015 - 'Health Care Choice Act' All provisions pertaining to the bill. S 1244 - 'Long-Term Care & Retirement Security Act of 2005' All provisions pertaining to the bill. S 1418 - 'Wired for Health Care Quality Act' All provisions pertaining to the bill. S 1569 - 'State Long Term Care Partnership Act of 2005' All provisions pertaining to the bill. S 1602 - 'Long-Term Care Choices Act of 2005' All provisions pertaining to the bill. S 1659 - 'State Long-Term Care Partnership Act of 2005' All provisions pertaining to the bill. S 1932 - 'Deficit Reduction Act of 2005' All provisions pertaining to long-term care and Medicaid reform. S 1955 - 'Health Insurance Marketplace Modernization & Affordability Act of 2005' All provisions pertaining to small group reform. S 2300 - 'Lower PRICED Drugs Act' All provisions pertaining to the bill. HR 525/994 - 'Small Business Health Fairness Act': all provisions related to the allowance of federal, civilian and military retirees to pay health insurance premiums on a pre-tax basis, and allowing tax deductions for TRICARE supplemental premiums. HR 534 - 'Help Efficient, Accessible, Low-Cost, Timely Healthcare ("HEALTH") Act All provisions related to the bill HR 976 - 'Long-Term Care Act of 2005' All provisions related to the bill. HR 1227 - 'Genetic Information Non-Discrimination Act' All provisions related to the bill. HR 1872 - 'Health Coverage for the Uninsured Act' All provisions related to the bill. HR 2071 - 'Family Care Act' All provisions related to the bill. HR 2355 - 'Health Care Choice Act' All provisions related to the bill. HR 2682 - 'Long Term Care and Retirement Security Act' All provisions related to the bill. HR 2830 - 'Pension Protection Act' All provisions related to the bill. HR 3204 - 'State High Risk Pool Funding Extension Act of 2005' All provisions related to the bill. HR 3511 - 'Medicaid State Long Term Care Partnership Program Act of 2005' All provisions related to the bill. HR 4157 - 'Health Information Technology Promotion Act' All provisions related to the bill. HR 4241 - 'Budget Reconciliation' All provisions related to health care or similar budget amounts. HR 4511 - 'Flex Saving Accounts Act of 2005' All provisions related to the bill. HR 5262 - 'Tax Free Health Savings Act of 2006' All provisions pertaining to the bill. HR 5384 - 'Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007' All provisions related to additional emergency funding to aid FDA backlog. S 4 - 'Healthy America Act of 2005' All provisions pertaining to the bill. S 5 - 'Class Action Fairness' All provisions pertaining to the bill. S 109 - 'Pharmaceutical Market Access Act' All provisions pertaining to the bill. S 160 - 'S.A.V.E. Act' All provisions pertaining to the bill. S 184 - 'Safe Import Act' All provisions pertaining to the bill. S 288 - 'State High Rick Poll Funding Extension Act' All provisions pertaining to the bill. S 306 - 'Genetic Information Nondiscrimination Act' All provisions pertaining to the bill. S 309 - which proposes to amend the IRS Code of 1986 to provide for the disposition of unused health benefits in cafeteria and flexible spending arrangements. All provisions pertaining to the bill. S 354 - 'The Long Term Care and Retirement Security Act of 2003' All provisions pertaining to the bill. HR 218 - 'Health Care Tax Deduction Act' All provisions related to the bill.

Client expense: $250,000 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Treasury, Dept of, White House Office

S. 109- Pharmaceutical Market Access Act of 2005; S. 184-Safe Import Act of 2005; H.R. 700, S. 334-Pharmaceutical Market Access and Drug Safety Act of 2005; and S. 930 Food & Drug Administration Safety Act of 2005.

Client expense: Not reported · Firm income: $120,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.870, Pharmaceutical Research and Manufacturers Accountability Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.16, Affordable Health Care Act, Lobbied to prevent provisions adverse to prescription drug approval process. S.930, Food and Drug Administration Safety Act of 2005, Lobbied to prevent adverse to prescription drug approval process. S.184, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. S.470, FACT Act, Fair Access to Clinical Trials Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.3650, The Helping to Fill the Medicare Rx Gap Act, Lobbied for final passage of the bill. H.R.2090, Food and Drug Administration Improvement Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. H.R.753, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs.

Client expense: $2,980,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 753 / S 184, Safe IMPORT Act of 2005, issues impacting employer costs. HR 2355 / S 1015, Health Care Choice Act of 2005, issues impacting employer costs. Issues related to health care cost containment. HR 525 / S 406, Small Business Health Fairness Act of 2005, issues impacting employer costs. HR 700 / S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, issues impacting employer costs. CONTINUED ON NEXT PAGE

Client expense: Not reported · Firm income: $960,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

S 222, S 873, S 581, S 345, S 18, S 877, S 1074, S 747, S 334, S 239, S 109, S 184, S 3, S 2493, S 2328, S 2307, S 1307, S 991 HR 918, HR 752, HR 2664, HR 2774, HR 2948, Hr 328, Hr 2427, H Con Res 95, HR 2830, HR 3045

Client expense: Not reported · Firm income: $33,750

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 222, S 873, S 581, S 345, S 18, S 877, S 1074, S 747, S 334, S 239, S 109, S 184, S 3, S 2493, S 2328, S 2307, S 1307, S 991 HR 918, HR 752, HR 2664, HR 2774, HR 2948, Hr 328, Hr 2427, H Con Res 95, HR 2830, HR 3045

Client expense: Not reported · Firm income: $33,750

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 222, S 873, S 581, S 345, S 18, S 877, S 1074, S 747, S 334, S 239, S 109, S 184, S 3, S 2493, S 2328, S 2307, S 1307, S 991 HR 918, HR 752, HR 2664, HR 2774, HR 2948, Hr 328, Hr 2427, H Con Res 95, HR 2830, HR 3045

Client expense: Not reported · Firm income: $33,750

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 222, S 873, S 581, S 345, S 18, S 877, S 1074, S 747, S 334, S 239, S 109, S 184, S 3, S 2493, S 2328, S 2307, S 1307, S 991 HR 918, HR 752, HR 2664, HR 2774, HR 2948, Hr 328, Hr 2427, H Con Res 95, HR 2830, HR 3045

Client expense: Not reported · Firm income: $33,750

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 222, S 873, S 581, S 345, S 18, S 877, S 1074, S 747, S 334, S 239, S 109, S 184, S 3, S 2493, S 2328, S 2307, S 1307, S 991 HR 918, HR 752, HR 2664, HR 2774, HR 2948, Hr 328, Hr 2427, H Con Res 95, HR 2830, HR 3045

Client expense: Not reported · Firm income: $33,750

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 222, S 873, S 581, S 345, S 18, S 877, S 1074, S 747, S 334, S 239, S 109, S 184, S 3, S 2493, S 2328, S 2307, S 1307, S 991 HR 918, HR 752, HR 2664, HR 2774, HR 2948, Hr 328, Hr 2427, H Con Res 95, HR 2830, HR 3045

Client expense: Not reported · Firm income: $33,750

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 22 Postal Accountability and Enhancement Act HR 184 Controlled Substances Export Reform Act of 2005 HR 218 Health Care Tax Deduction Act of 2005 HR 328 Pharmaceutical Market Access Act of 2005 HR 700 Pharmaceutical Market Access and Drug Safety Act of 2005 HR 753 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 HR 747 National Health Information Incentive Act of 2005 HR 1132 National All Schedules Prescription Electronic Reporting Act of 2005 HR 1223 Information Technology for Health Care Quality Act HR 4832 Electronic Health Information Technology Act of 2006 HR 4157 Health Information Technology Promotion Act of 2005 HR 5166 Independent Pharmacy Protection Act of 2006 HR 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 HR 1626 Medicare Prescription Drug Improvement Act HR 1669 Pharmacy Benefit Manager Transparency Act of 2005 HR 1671 Community Pharmacy Fairness Act of 2005 HR 1710 Internet Police Protection Act of 2005' HR 1808 Safe Online Drug Act of 2005 HR 2234 21st Century Health Information Act of 2005 HR 2664 Biennial Budgeting and Appropriations Act of 2005 HR 2774 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2006 HR 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2007 S 4 Healthy America Act of 2005 S 16 Affordable Health Care Act S 109 Pharmaceutical Market Access Act of 2005 S 184 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 S 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S 518 National All Schedules Prescription Electronic Reporting Act of 2005 S 662 Postal Accountability and Enhancement Act S 975 Project BiosSheild II Act of 2005 S 1223 Information Technology for Health Care Quality Act S 1227 Health Information Technology Act of 2005 S 1262 Health Technology to Enhance Quality Act of 2005 S 1418 Wired for Health Care Quality Act S 2072 Medicare Early Access Act of 2005 S 2090 Food and Drug Administration Act of 2005 S 2551 Prompt Payment of Health Benefits Claims Act of 2006 S 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 S. 2665 Pharmacy Access Improvement (PhAIm) Act of 2006 See next page

Client expense: Not reported · Firm income: $160,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 22 Postal Accountability and Enhancement Act HR 184 Controlled Substances Export Reform Act of 2005 HR 218 Health Care Tax Deduction Act of 2005 HR 328 Pharmaceutical Market Access Act of 2005 HR 700 Pharmaceutical Market Access and Drug Safety Act of 2005 HR 753 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 HR 747 National Health Information Incentive Act of 2005 HR 1132 National All Schedules Prescription Electronic Reporting Act of 2005 HR 1223 Information Technology for Health Care Quality Act HR 4832 Electronic Health Information Technology Act of 2006 HR 4157 Health Information Technology Promotion Act of 2005 HR 5166 Independent Pharmacy Protection Act of 2006 HR 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 HR 1626 Medicare Prescription Drug Improvement Act HR 1669 Pharmacy Benefit Manager Transparency Act of 2005 HR 1671 Community Pharmacy Fairness Act of 2005 HR 1710 Internet Police Protection Act of 2005' HR 1808 Safe Online Drug Act of 2005 HR 2234 21st Century Health Information Act of 2005 HR 2664 Biennial Budgeting and Appropriations Act of 2005 HR 2774 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2006 HR 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2007 S 4 Healthy America Act of 2005 S 16 Affordable Health Care Act S 109 Pharmaceutical Market Access Act of 2005 S 184 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 S 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S 518 National All Schedules Prescription Electronic Reporting Act of 2005 S 662 Postal Accountability and Enhancement Act S 975 Project BiosSheild II Act of 2005 S 1223 Information Technology for Health Care Quality Act S 1227 Health Information Technology Act of 2005 S 1262 Health Technology to Enhance Quality Act of 2005 S 1418 Wired for Health Care Quality Act S 2072 Medicare Early Access Act of 2005 S 2090 Food and Drug Administration Act of 2005 S 2551 Prompt Payment of Health Benefits Claims Act of 2006 S 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 S. 2665 Pharmacy Access Improvement (PhAIm) Act of 2006 See next page

Client expense: Not reported · Firm income: $160,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 22 Postal Accountability and Enhancement Act HR 184 Controlled Substances Export Reform Act of 2005 HR 218 Health Care Tax Deduction Act of 2005 HR 328 Pharmaceutical Market Access Act of 2005 HR 700 Pharmaceutical Market Access and Drug Safety Act of 2005 HR 753 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 HR 747 National Health Information Incentive Act of 2005 HR 1132 National All Schedules Prescription Electronic Reporting Act of 2005 HR 1223 Information Technology for Health Care Quality Act HR 4832 Electronic Health Information Technology Act of 2006 HR 4157 Health Information Technology Promotion Act of 2005 HR 5166 Independent Pharmacy Protection Act of 2006 HR 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 HR 1626 Medicare Prescription Drug Improvement Act HR 1669 Pharmacy Benefit Manager Transparency Act of 2005 HR 1671 Community Pharmacy Fairness Act of 2005 HR 1710 Internet Police Protection Act of 2005' HR 1808 Safe Online Drug Act of 2005 HR 2234 21st Century Health Information Act of 2005 HR 2664 Biennial Budgeting and Appropriations Act of 2005 HR 2774 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2006 HR 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2007 S 4 Healthy America Act of 2005 S 16 Affordable Health Care Act S 109 Pharmaceutical Market Access Act of 2005 S 184 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 S 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S 518 National All Schedules Prescription Electronic Reporting Act of 2005 S 662 Postal Accountability and Enhancement Act S 975 Project BiosSheild II Act of 2005 S 1223 Information Technology for Health Care Quality Act S 1227 Health Information Technology Act of 2005 S 1262 Health Technology to Enhance Quality Act of 2005 S 1418 Wired for Health Care Quality Act S 2072 Medicare Early Access Act of 2005 S 2090 Food and Drug Administration Act of 2005 S 2551 Prompt Payment of Health Benefits Claims Act of 2006 S 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 S. 2665 Pharmacy Access Improvement (PhAIm) Act of 2006 See next page

Client expense: Not reported · Firm income: $160,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR.2234 – 21st Century Health Information Act HR.3204 – State High Risk Pool Funding Extension Act HR.4157 – Health Information Technology Promotion Act of 2005 S.109 – Pharmaceutical Market Access Act of 2005 S.1227 – Health Information Technology Act of 2005 S.1262 – Health Technology to Enhance Quality Act S.1332 – Personal Data Privacy and Security Act S.1337 – Fair and Reliable Medical Justice Act S.1355 – Better Healthcare Through Information Technology Act S.1355 – Health Information Technology Quality and Improvement Act S.1408 – Identity Theft Protection Act S.1418 – Wired for Health Care Quality Act S.16 – Affordable Health Care Act S.1789 – Personal Data Privacy and Security S.184 – Safe Importation of Medical Products and Other Rx Therapies Act of 2005 S.2607 – Small Business Health Education and Awareness Act of 2006 S.288 – State High Risk Pool Funding Extension Act S.306 – Genetic Information Nondiscrimination Act S.354 – Help Efficient, Accessible, Low-Cost, Timely Healthcare Act of 2005 S.518 – National All Schedules Prescription Electronic Reporting Act of 2005 S.544 – Patient Safety and Quality Improvement Act S.751 – Notification of Risk to Personal Data Act FDA new application review

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 334/H.R. 700 - Pharmaceutical Market Access & Drug Safety Act of 2005; H.R. 328/S. 109/S. 184 - Pharmaceutical Market Access of 2005S

Client expense: $31,440,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Highway Administration (FHA), Federal Trade Commission (FTC), Federal Transit Administration (FTA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Aeronautics & Space Administration (NASA), Natl Labor Relations Board (NLRB), Natl Oceanic & Atmospheric Administration (NOAA), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of the Vice President of the United States, Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

H.R. 525/S. 406/S. 1955 - AHPs/SBHPs H.R. 1872/S. 978/H.R. 5262/H.R. 4511/S. 2554/S. 2549/S. 2424/S. 2494/S. 2379 -HSAs/Tax Credits H.R. 1998/S. 309/H.R. 2830 - FSA Rollover H.R. 534/S. 354 - Medical Liabilty Reform S. 334/H.R. 700 - Pharmaceutical Market Access & Drug Safety Act of 2005 H.R. 328/S. 109/S. 184 - Pharmaceutical Market Access of 2005 H.R. 2355/S. 1015 - Internet National Market, Health Care Choice Act H.R. 2234 - 21st Century Health IT Act S. 1955 - Health Insurance Modernization and Affordability Act of 2005 S. 1418 - Wired for Health Care Quality Act H.R. 4157 - Health IT H.R. 4511 - Flex Health Savings Accounts Act of 2005 H.R. 6111, The Tax Relief and Health Care Act of 2006 S. 3488 Tax-Free Healthcare Savings, Access and Portability Act S. 2549, Health Savings Account Affordability Act S. 2494, to amend the Internal Revenue Code of 1986 S. 2424, to amend the Internal Revenue Code of 1986 S. 978, Healthcare Tax Relief for the Uninsured Act of 2005 S. 406: Small Business Health Fairness Act S. 2607: Small Business Health Education and Awareness Act of 2006 H.R. 525: Small Business Health Fairness Act Health Care Costs for Small Business Health Savings Accounts H.R. 6111: "The Tax Relief and Health Care Act of 2006"

Client expense: $31,440,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Highway Administration (FHA), Federal Trade Commission (FTC), Federal Transit Administration (FTA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Aeronautics & Space Administration (NASA), Natl Labor Relations Board (NLRB), Natl Oceanic & Atmospheric Administration (NOAA), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of the Vice President of the United States, Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

S. 334/H.R. 700 - Pharmaceutical Market Access & Drug Safety Act of 2005,H.R. 328/S. 109/S. 184 - Pharmaceutical Market Access of 2005 H.R. 2355/S. 1015 - Internet National Market, Health Care Choice Act S. 1418 - Wired for Health Care Quality Act H.R. 4157 - Health IT S. 1408, Identity Theft Protection Act S. 1332, Personal Data Privacy and Security Act S. 1326, Notification of Risk to Personal Data H.R. 2795, Patent Reform Act of 2005 S. 3658, The Customs and Trade Facilitation Reauthorization Act of 2006 H.R. 5249/S. 3800 - the Stop Aid to Counterfeiters Act H. R. 5156 - the Counterfeit Drug Prevention Act of 2006 S. 751, Notification of Risk to Personal Data Act H.R. 3375, Financial Data Security Act H.R. 4127, Data Accountability and Trust Act

Client expense: $31,440,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Highway Administration (FHA), Federal Trade Commission (FTC), Federal Transit Administration (FTA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Aeronautics & Space Administration (NASA), Natl Labor Relations Board (NLRB), Natl Oceanic & Atmospheric Administration (NOAA), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of the Vice President of the United States, Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

H.R. 1626, the Medicare Prescription Drug Improvement Act Issues pertaining to the prevention of misuse of products containing DMX, including the Dextromethorphan Distribution Act Issues relating to the distribution practices of contact lens manufacturers, including H.R. 1800 and S. 2480 Issues relating to H.R. 5533, the Biodefense and Pandemic Vaccine Drug Development Act Issues regarding the effective date of elements of S. 103, the Combat Meth bill Issues pertaining to the treatment of malaria Issues pertaining to the importation of prescription drugs, including: S. 334, the Pharmaceutical Market Access and Drug Safety Act S. 184, the Safe Import Act S. 109 the Pharmaceutical Market Access Act

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.1418 – Wired for Health Care Quality Act S.16 – Affordable Health Care Act S.184 – Safe Importation of Medical Products and Other Rx Therapies Act of 2005 S.518 – National All Schedules Prescription Electronic Reporting Act of 2005 HR.2234 – 21st Century Health Information Act H.R.4157 – Health Information Technology Promotion Act of 2005 S.109 – Pharmaceutical Market Access Act of 2005 S.1262 – Health Technology to Enhance Quality Act

Client expense: Not reported · Firm income: $75,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

reducing subsidies to private Medicare Part D plans; 4) S. 3647 pertaining to Medicare Part D's coverage gap; 5) H.R. 5969 pertaining to Part D’s low-income subsidy and asset test; 6) S. 334, H.R. 700, H.R. 328, S. 109, S. 184, H.R. 753, H.R. 5441 pertaining to restrictions placed on the commercial and private importation of prescription drugs; 7) H.R. 376, S. 445 authorizing the Secretary of Health and Human Services to negotiate lower prescription drug prices with manufacturers; 8) H.R. 916, S. 438, H.R. 6111 pertaining to the Medicare Part B outpatient rehabilitation services therapy caps; 9) H.R. 2072, S. 3747: provisions pertaining to access to Medicare for individuals ages 55 to 65 and authorizing a refundable and “advanceable” credit against income tax for premium payments; 10) S. 1152, H.R. 1125 amending Medicare’s coinsurance for outpatient mental health care; 11) S. 1335 to preserve Medicare beneficiaries’ appeal rights; 12) S. 347, H.R. 2058, S. 570 providing Medicare beneficiaries with a free physician office visit to discuss end-of-life care in conjunction with preparing advance directives; 13) H.R. 5147 eliminating Medicare Part B premium means-testing; 14) S. 1889, H.R. 4122, H.R. 5552, S. 3491, H.R. 3282, H.R. 2470, S. 1155, S. 3521: provisions pertaining to the creation of sunset and/or entitlement commissions affecting Medicare and the 45% Medicare funding cap; 15) encouraging the Secretary of Health and Human Services to use his demonstration authority to waive Medicare Part D’s late enrollment penalty for beneficiaries affected by Hurricane Rita (no resolution or bill was pending). Medicaid. 1) H.R. 1229, S. 489 limiting the duration of federal consent decrees to which states and local governments are parties; 2) P.L. 109-171: provisions affecting proof of citizenship requirements for continued Medicaid eligibility; 3) S. 1889, H.R. 4122, H.R. 5552, S. 3491, H.R. 3282, H.R. 5766, H.R. 2470, S. 1155, S. 3521: provisions pertaining to the creation of sunset and/or entitlement commissions affecting Medicaid. 1) S. 345, S. 873, H.R. 752, S. 2342 creating a Medicare-operated Part D benefit with negotiated prescription drug prices; 2) H.R. 3861, H.R. 5969, S. 1841, S. 3654 extending/waiving the late enrollment penalty for Part D; 3) S. 1589, H.R. 6111 eliminating/

Client expense: $4,580,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1626, the Medicare Prescription Drug Improvement Act Issues pertaining to the importation of prescription drugs, including: S. 334, the Pharmaceutical Market Access and Drug Safety Act S. 184, the Safe Import Act S. 109, the Pharmaceutical Market Access Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 525, S 406, Small Business Health Fairness Act of 2005, issues affecting employer costs. HR 700, S. 334, Pharmaceutical Market Access and Drug Safety Act of 2005, issues affecting employer costs. HR 753, S. 184, Safe IMPORT Act of 2005, issues affecting employer costs. CONTINUED ON NEXT PAGE

Client expense: $864,600 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

H.R.2090, Food and Drug Administration Improvement Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. H.R.753, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. H.R.870, Pharmaceutical Research and Manufacturers Accountability Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.16, Affordable Health Care Act, Lobbied to prevent provisions adverse to prescription drug approval process. S.930, Food and Drug Administration Safety Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.184, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. S.470, FACT Act, Fair Access to Clinical Trials Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.3650, The Helping to Fill the Medicare Rx Gap Act, lobbied for final passage of the bill.

Client expense: $2,760,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 563 -- Require secretary of HHS to negotiate prescription drug prices and permit re-importation. H.R. 578 -- Amend the IRS code to allow importation of drugs for retirees. H.R. 700 -- Amend the FDA Act to allow the importation of prescription drugs. H.R. 1083 -- To amend the Controlled Substances Act with respect to the regulation of ephedrine alkaloids, including ephedrine and pseudoephedrine. H.R. 1446 -- To amend the Controlled Substances Act to eliminate the safe harbor exception for certain packaged pseudoephedrine products. H.R. 1350 -- To amend the Controlled Substances Act to eliminate the safe harbor exception for certain packaged pseudoephedrine products. H.R. 1378 -- To amend the Controlled Substances Act with respect to the regulation of ephedrine alkaloids, including ephedrine and pseudoephedrine. H.R. 1808 -- To amend the FDA Act to create a uniform certification standard for Internet pharmacies. Monitored S. 184 -- Amend the FDA Act to protect the public from the unsafe reimportation of prescription drugs. S. 334 -- Pharmaceutical Market Access and Drug Safety Act H.R. 13 -- To respond to the illegal production, distribution and use of methamphetamines.

Client expense: $20,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)

H.R.2090, Food and Drug Administration Improvement Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. H.R.753, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. H.R.870, Pharmaceutical Research and Manufacturers Accountability Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.16, Affordable Health Care Act, Lobbied to prevent provisions adverse to prescription drug approval process. S.930, Food and Drug Administration Safety Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.184, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. S.470, FACT Act, Fair Access to Clinical Trials Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process.

Client expense: $2,580,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 16: A bill to reduce to the cost of quality health care coverage and improve the availability of health care coverage for all Americans. Lobbied to protect the interests of the Biotech drug industry. S. 109, H.R. 328: A bill entitled the "Pharmaceutical Market Access Act of 2005". Lobbied for an exemption for biologics.S.184,H.R. 753: A bill to amend the Federal Food, Drug, and Cosmetic Act to protect the public health from the unsafe importation of prescription drugs and from counterfeit prescription drugs, and for other purposes. Lobbied for an exemption for biologics. S. 334, H.R. 700: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. Lobbied for an exemption for biologics. H.R. 563: To amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate and disclose lowest possible prices for prescription drug prices for Medicare beneficiaries, and with respect to the Federal Food, Drug, and Cosmetic Act, to provide waivers that permit such beneficiaries to import prescription drugs from Canada. Lobbied for an exemption for biologics. H.R. 578: To amend the Internal Revenue Code of 1986 with respect to the purchase of prescription drugs by individuals who have attained retirement age, and to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs and the sale of such drugs through Internet sites. Lobbied for an exemption for biologics. H.R.1626: To amend part D of the title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negptiate for lower prices for Medicare prescription drugs and to eliminate the gap in coverage of Medicare prescrition durg benefits, to the Secretary of Health and Human Services to promulgate regulations for the reimportation of prescription drugs, and for other purposes. Lobbied for an exemption for biologics. H.R. 2599: To improve the quality, availability, diversity, personal privacy, and innovation of health care in the United States. Lobbied for an exemption for biologics.. H.R.16: To authorize the use of Federal funds for research on human embryonic stem cells irrrespective of the date on which such stem cells were derived, and for other purposes. Lobbied to prevent the unreasonable restriction of legitimate medical research or clinical trials. H.R. 596, S. 681: To amend the Public Health Service Act to establish a National Cord Blood Stem Cell Bank Network to prepare, store, and distribute human umbilical cord blood stem cells for the treatment of patients and to support peer-reviewed research using such cells. Lobbied to prevent the unreasonable restriction of legitimate medical research or clinical trials. H.R. 810, S. 471: To amend the Public Health Service Act to provide for human embryonic stem cell research. H.R.1650: To amend the Internal Revenue Code of 1986 to allow tax credits to holders of stem cell research bonds. Lobbied to prevent the unreasonable restriciton of legitimate medical research or clinical trials. H.R. 1822, S. 876: To prohibit human cloning and protect stem cells research. Lobbied to prevent the unreasonable restriction of legitimate medical research or clinical trials. H.R. 2541: To amend the Public Health Service Act to provide for the expansion, intensification, and coordination of the activities of the National Institutes of Health regarding qualifying adult stem cell research, and for other purposes. Lobbied to prevent the unreasonable restriction of legitimate medical research or clinical trials. H.R.2520, S.1317: To provide for the collection and maintenance of human cord blood stem cells for the treatment of patients and research, and to amend the Public Health Service Act to authorize the C.W. Bill Young Cell Transplantation Program. Lobbied to prevent the unreasonable restriction of legitimate medical research or clinical trials. H.R. 2574: To amend the Public Health Service Act to provide for a program at the National Institutes of Health to conduct and support research on animals to develop techniques for the derivation of stem cells from embryos that do not harm the embryos, and for other purposes. Lobbied to prevent the unreasonable restriction of legitimate medical research or clinical trials. S.1392: A bill to reauthorize the Federal Trade Commission. (Dorgan/Snowe Drug Importation Amendment). Lobbied for an exemption for biologics. H.R.3144: To amend the Public Health Service Act to provide for a program at the National Institutes of Health to conduct and support research in the derivation and use of human pluripotent stem cells by means that do not harm human embryos, and for other purposes. Lobbied for the interests of the vaccine industry. H.R.3423,S.1420: To amend the Federal Food, Drug, and Cosmetic Act with respect to medical device user fees. Lobbied for the interests of the medical device industry. S.226: A bill to amend the Public Health Service Act to improve immunization rates by increasing the supply of vaccines. Lobbied for the interst of the vaccine industry. S.521,H.R.1290: A bill to amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish, promote, and support a comprehensive prevention, research, and medical management referral program for hepatitis C virus infection. Supported bill. S.969,H.R.3369: A bill to amend the Public Health Service Act with respect to preparation for an influenza pandemic, including an avian influenza pandemic, and for other purposes. Lobbied for the interests of the vaccine industry. S.1422,H.R.881: A bill to amend the Federal Food, Drug, and Cosmetic Act to reduce human exposure to mercury through vaccines. Lobbied for the interests of the vaccine industry. H.R.650: To establish reasonable legal reforms that will facilitate the manufacture of vital, life-saving vaccines, and for other purposes. Lobbied for the interests of the vaccine industry. H.R.1297: To amend the Public Health Service Act with respect to the National Vaccine Injury Compensation Program. Lobbied for the interests of the vaccine industry. S.930: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to drug safety, and for other purposes. Lobbied to prevent the unreasonable restricition of legitimate medical research or clinical trials. S.470: A bill to amend the Public Health Service Act to expand the clinical trials drug data bank. Lobbied to provide the best information to the patient. H.R.2090: To amend the Federal Food, Drug, and Cosmetic Act to provide for the deposit in the general fund of the Treasury of fees that are collected from manufacturers of drugs and devices under chapter VII of such Act, to terminate the authority of the Food and Drug administration to negotiate with the manufacturers on particular uses of the fees, to establish a Center for Postmarket Drug Safety and Effectiveness, to establish additional authorities to ensure the safe and effective use of drugs, and for other purposes. Lobbied for provisions that promoted the development safe and effective drugs. H.R.2124,H.R.2308: To amend the Public Health Service Act to provide for clinical research support grants, clinical research infrastructure grants, and a demonstration program on partnerships in clinical research, and for other purposes. Lobbied for reasonable provisions that support research and clinical trials. H.R.2650: To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to protect consumers in managed care plans and other health coverage. Lobbied for the interests of the industry. H.R.2792: To permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests, and for other purposes. Lobbied for the interests of the industry. H.R.3196,H.R.2259,S.1012: To amend the Public Health Service Act to expand the scope of information required for the data bank on clinical trials of drugs, and for other purposes. Lobbied for reasonable provisions that support research and clinical trials. S.1128: A bill to amend title XIX of the Social Security Act to provide for increased rebates under the medicaid program for prescription drugs that are directly advertised to consumers, to require other Federal programs purchasing or reimbursing for such drugs to establish payment and reimbursement mechanisms that reduce the costs of those drugs, and for other purposes. Lobbied to ensure that any enacted restrictions would not impede access of the consumer to accurate information about pharmaceutical products. H.R.840,S.399: A bill to amend the Federal Food, Drug and Cosmetic Act with respect to the sale of prescription drugs through the internet, and for other purposes. Lobbied to ensure that the internet would not be used to import counterfeit and defective medical products. H.R.1808,S.334: To amend the Federal Food, Drug, and Cosmetic Act to create a uniform certification standard for Internet pharmacies and to prohibit Internet pharmacies from engaging in certain advertising activities, to prohibit the use of certain bank instruments for purchases associated with illegal Internet pharmacies, and for other purposes. Lobbied to ensure that the internet would not be used to import counterfeit and defective medical products. H.R.4395: To amend titles XVIII and XIX of the Social Security Act to provide for an improved voluntary Medicare prescription drug benefit, to provide greater access to affordable pharmaceuticals, and for other purposes. Lobbied for an exemption for biologics in the Drug Importation section. S.470: A bill to amend the Public Health Service Act to expand the clinical trials drug data bank. Lobbied to prevent the unreasonable restriction of legitimate medical research or clinical trials. S.930: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to drug safety, and for other purposes. Lobbied to prevent the unreasonable restricition of legitimate medical research or clinical trials. S.1873: A bill to prepare and strengthen the biodefenses of the United States against deliberate, accidental, and natural outbreaks of illness, and for other purposes. Lobbied for a vaccine liability and compensation program for Pandemic Vaccines. H.R.2345: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. Lobbied in support of enhanced FDA authorities over counterfeit products. H.R.3052,S.1527: Vaccine Access and Supply Act, lobbied for provisions to strengthen the domestic vaccine industry. H.R.3970: Bioterror and Pandemic Preparedness Protection Act, lobbied in support of provisions to assure domestic pandemic preparedness. S.1821: Pandemic Preparedness and Response Act, lobbied in support of provisions to assure domestic pandemic preparedness. S.1828: Influenza Vaccine Security Act of 2005, lobbied in support of provisions to assure as strong domestic vaccine industry. S.1912: Global Network for Avian Influenza Surveillance Act, lobbied in support of domestic pandemic preparedness. S.375: Flu Protection Act of 2005, lobbied in support of domestic influenza provisions to stabilize production and supply. S.969: Attacking Viral Influenza Across Nations Act of 2005, lobbied in support of influenza provisions. General matters related to vaccine industry stability, pandemic preparedness, avian influenza.

Client expense: Not reported · Firm income: $100,000

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

S.3 "Bio-preparedness Act" S.1262 "Health Technology to Enhance Quality Act" S.16 "Affordable Health Care Act" S.109 "Pharmaceutical Market Access Act of 2005" S.184 "Safe Importation of Medical Products and Other Rx Therapies Act of 2005" S.518 "National All Schedules Prescription Electronic Reporting Act of 2005"S.975 "Project BioSheild II Act of 2005" S1418 "Wired for Health Care Quality Act" HR.2234 "21 Century Health Information Act"

Client expense: Not reported · Firm income: $75,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1957 Asbestos Compensation Fairness Act of 2005 H.R. 3045 Dominican Republic-Central America-United States Free Trade Agreement Implementation Act H.R. 729 Medicare Drug Cost Credibility Act of 2005 S. 1307 Dominican Republic-Central America-United States Free Trade Agreement Implementation Act S. 184 Safe IMPORT Act of 2005 Safe Importation of Medical Pruducts and other Rx Therapies Act of 2005

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 525, S.406, Small Business Health Fairness Act of 2005, issues impacting employer costs. H.R. 700, S. 334, Pharmaceutical Market Access and Drug Safety Act of 2005, issues impacting employer costs. H.R. 753, S. 184, Safe IMPORT Act of 2005, issues impacting employer costs. H.R. 2355, S. 1015, Health Care Choice Act of 2005, issues impacting employer costs.

Client expense: Not reported · Firm income: $640,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE